University of Cincinnati: AI Advances in the Liver Disease Field
April 16, 2026
April 16, 2026
CINCINNATI, Ohio, April 16 -- The University of Cincinnati posted the following news:
* * *
AI advances in the liver disease field
UC transplant hepatologist reviews the clinical landscape's current technology
By Megan Burgasser, burgasma@ucmail.uc.edu
MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease), where fat . . .
* * *
AI advances in the liver disease field
UC transplant hepatologist reviews the clinical landscape's current technology
By Megan Burgasser, burgasma@ucmail.uc.edu
MASH represents the advanced inflammatory form of metabolic dysfunction-associated steatotic liver disease (MASLD, formerly known as nonalcoholic fatty liver disease), where fat . . .